Multiple Myeloma

Encouraging Initial Data From Ongoing Phase 1/2 Trial of TH-302 Plus Bortezomib (Velcade(R)) Plus Dexamethasone ("TBorD") in Patients With Relapsed/Refractory Multiple Myeloma Presented at ASH Annual Meeting
Yahoo/MarketWired
Sun, 12/7/14 - 09:09 am
TH-302
Threshold Pharmaceuticals
Multiple Myeloma
Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma
Yahoo/PR Newswire
Sat, 12/6/14 - 11:18 am
Amgen
ONYX Pharmaceuticals
Kyprolis
Multiple Myeloma
Priority review period for Novartis cancer drug extended
Seeking Alpha
Tue, 11/25/14 - 09:57 am
Novartis
Multiple Myeloma
panobinostat
bortezomib
The FDA's Oncologic Drugs Advisory Committee Will Likely Vote Against Novartis' Panobinostat
Seeking Alpha
Thu, 11/6/14 - 09:47 am
FDA
advisory panels
Novartis
panobinostat
Multiple Myeloma
Record Number of Clinical Trials for Multiple Myeloma this Year
Drug Discovery and Development
Sun, 10/5/14 - 10:34 am
Multiple Myeloma
J&J And Bristol-Myers Changing The Myeloma Drug Landscape
Bidness
Sun, 08/31/14 - 10:03 am
JNJ
Bristol-Myers Squibb
myeloma
Multiple Myeloma
Amgen: Why No One Cares About Kyprolis Trial Failure
Barron's
Fri, 08/15/14 - 05:21 am
Amgen
Kyprolis
Multiple Myeloma
Why Amgen, Inc.’s Kyprolis FOCUS Failure Is a Big Deal
Motley Fool
Thu, 08/14/14 - 08:43 am
Amgen
Kyprolis
Multiple Myeloma
Amgen Drops in After Hours on Failed Trial, Recall
Barron's
Wed, 08/13/14 - 04:36 pm
Amgen
Kyprolis
recalls
Aranesp
Multiple Myeloma
Amgen reports positive trial of multiple myeloma treatment
Marketwatch
Mon, 08/4/14 - 08:57 am
Amgen
Multiple Myeloma
Kyprolis
Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Pipeline Review
Sat, 07/19/14 - 09:26 am
daratumumab
Multiple Myeloma
Will Amgen’s Acquisition of Onyx Pay off Soon?
Motley Fool
Thu, 06/26/14 - 09:36 am
M&A
Amgen
ONYX Pharmaceuticals
Kyprolis
Multiple Myeloma
Novartis bone marrow drug improves progression-free survival
Yahoo/Reuters
Mon, 06/2/14 - 10:04 am
Novartis
LBH589
Multiple Myeloma
ASCO
Stemline's SL-401 significantly decreased the viability of malignant cells
The Fly on the Wall
Tue, 05/20/14 - 11:23 am
Stemline Therapeutics
SL-401
Multiple Myeloma
Bristol-Myers, AbbVie granted breakthrough therapy designation for elotuzumab
The Fly on the Wall
Mon, 05/19/14 - 09:17 am
Bristol-Myers Squibb
AbbVie
elotuzumab
Multiple Myeloma
Spectrum Pharma's cancer drug meets main goal in trial
Yahoo/Reuters
Wed, 04/23/14 - 08:44 am
Spectrum Pharmaceuticals
melphalan
Multiple Myeloma
Novartis: 2 Novel Cancer Therapies Show Promising Results
Seeking Alpha
Wed, 12/11/13 - 02:42 pm
Novartis
Celgene
JNJ
Merck
panobinostat
Multiple Myeloma
acute lymphocytic leukemia
Celgene advances after analysts say Revlimid data positive
The Fly on the Wall
Mon, 12/9/13 - 11:29 am
Revlimid
Celgene
Multiple Myeloma
Novartis bone marrow cancer drug meets goal in late-stage study
Yahoo/AP
Fri, 12/6/13 - 09:01 am
Novartis
LBH589
Multiple Myeloma
Celgene's Revlimid Faces a Tough Sell
Motley Fool
Tue, 11/19/13 - 07:25 am
Celgene
Revlimid
JNJ
Multiple Myeloma

Pages